Valneva SE ADR (VALN): Next-Year EPS Estimate 186.42%
As of 2026-06-04, Valneva SE ADR (VALN) has a next-year EPS growth estimate of 186.42%.
On 2026-05-19, analyst consensus for VALN's next-year EPS growth shifted from 185.65% to 186.42% — a positive change of 0.77 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 43.99%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 186.42%
- EPS growth this year
- 43.99%
- EPS next quarter (est)
- -$0.19
- Last price
- $5.67
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 186.42% | 43.99% | -$0.19 | $5.67 |
| 2026-06-03 | 186.42% | 43.99% | -$0.19 | $5.58 |
| 2026-06-02 | 186.42% | 43.99% | -$0.19 | $5.63 |
| 2026-06-01 | 186.42% | 43.99% | -$0.19 | $5.95 |
| 2026-05-31 | 186.42% | 43.99% | -$0.19 | $6.25 |
| 2026-05-28 | 186.42% | 43.99% | -$0.19 | $6.30 |
| 2026-05-27 | 186.42% | 43.99% | -$0.19 | $6.34 |
| 2026-05-26 | 186.42% | 43.99% | -$0.19 | $6.05 |
| 2026-05-25 | 186.42% | 43.99% | -$0.19 | $5.93 |
| 2026-05-24 | 186.42% | 43.99% | -$0.19 | $5.93 |
| 2026-05-21 | 186.42% | 43.99% | -$0.19 | $5.87 |
| 2026-05-20 | 186.42% | 43.99% | -$0.19 | $5.92 |
| 2026-05-19 | 186.42% | 43.99% | -$0.19 | $5.76 |
| 2026-05-18 | 185.65% | 43.89% | -$0.19 | $5.71 |
| 2026-05-17 | 186.63% | 43.75% | -$0.19 | $5.68 |
| 2026-05-14 | 187.85% | 45.15% | -$0.17 | $5.94 |
| 2026-05-13 | 178.14% | 42.61% | -$0.16 | $5.86 |
| 2026-05-12 | 176.77% | 40.87% | -$0.16 | $6.00 |
| 2026-05-11 | 176.77% | 40.87% | -$0.16 | $6.30 |
| 2026-05-10 | 176.77% | 40.87% | -$0.16 | $5.59 |
| 2026-05-07 | 176.77% | 40.87% | -$0.16 | $5.56 |
| 2026-05-06 | 176.77% | 40.87% | -$0.16 | $5.41 |
| 2026-05-05 | 176.77% | 40.87% | -$0.16 | $5.29 |
| 2026-05-04 | 176.77% | 40.87% | -$0.16 | $5.17 |
| 2026-05-03 | 176.77% | 40.87% | -$0.16 | $5.35 |
| 2026-04-30 | 176.77% | 40.87% | -$0.16 | $5.38 |
| 2026-04-29 | 178.22% | 40.93% | -$0.16 | $5.33 |
| 2026-04-28 | 178.22% | 40.93% | -$0.16 | $5.53 |
| 2026-04-27 | 178.22% | 40.93% | -$0.16 | $5.49 |
| 2026-04-26 | 178.22% | 40.93% | -$0.16 | $5.50 |
Recent News
- Valneva SE (INRLF) Q1 2026 Earnings Call Highlights: Promising Vaccine Developments Amid ...GuruFocus.com
- Pfizer-Valneva Lyme disease vaccine falls short as low cases skew resultsClinical Trials Arena
- Mixed results for Lyme disease vaccine hit Valneva sharesAFP
- Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study resultsBioPharma Dive
- Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trialMarketWatch
- Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR TrialBusiness Wire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Valneva SE ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Valneva SE ADR (VALN) has a next-year EPS growth estimate of 186.42%, based on analyst consensus.
When was the latest EPS estimate revision for VALN?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 185.65% to 186.42%.
What sector and industry does Valneva SE ADR belong to?▾
Valneva SE ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VALN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Valneva SE ADR (VALN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports